Germany: New COVID-19 Vaccine Could Be Vital for Immunocompromised Patients | The World | DW
The COVID-19 vaccine known as CoVac-1 and developed by a team of scientists from the German University of Tübingen (in the federal state of Baden-Württemberg), has been shown to produce a strong response of white blood cells – or T cells – in all 36 participants during their first trial phase, offering new hope to … Read more